Skip to content
Menu

BTIG Reiterates Buy on Ascentage Pharma Group, Maintains $48 Price Target

Benzinga Newsdesk 1 day ago

Analyst RatingsNewsReiterationPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

BTIG analyst Jeet Mukherjee reiterates Ascentage Pharma Group (NASDAQ:AAPG) with a Buy and maintains $48 price target.

BTIG analyst Jeet Mukherjee reiterates Ascentage Pharma Group (NASDAQ:AAPG) with a Buy and maintains $48 price target.

Read at benzinga.com